Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Oxymorphone ER in Cancer Pain
NCT00904449Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Apr 2001
- Primary completion
- Dec 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxymorphone in cancer pain, sponsored by Endo International plc. Started Apr 2001; status: completed.
02
Drugs
oxymorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00904449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00904449.